CMCSA vs MDLZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 06, 2026

CMCSA

47.8
AI Score
VS
MDLZ Wins

MDLZ

48.7
AI Score

Investment Advisor Scores

CMCSA

48score
Recommendation
HOLD

MDLZ

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CMCSA MDLZ Winner
Revenue 61.40B 10.08B CMCSA
Net Income 5.70B 560.00M CMCSA
Net Margin 9.3% 5.6% CMCSA
Operating Income 9.30B 808.00M CMCSA
ROE 6.3% 2.2% CMCSA
ROA 2.2% 0.8% CMCSA
Total Assets 257.55B 71.12B CMCSA
Current Ratio 0.80 0.54 CMCSA
Free Cash Flow 9.73B 155.00M CMCSA

Relative Price Performance (Last 90 Days)

CMCSA 1M: +8.6% · 3M: -3.4% MDLZ 1M: +7.4% · 3M: +2.1%

Current Technical Phase

CMCSA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.2 · Price: $25.36

MDLZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.2 · Price: $62.61

Fundamentals Snapshot

Metric CMCSA MDLZ
Market Cap
Forward P/E 7.0 18.4
Trailing P/E 7.9 38.0
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.2%
EPS 3.17 1.64
Dividend Yield 0.05% 0.03%

Frequently Asked Questions

Based on our detailed analysis, MDLZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.